Downgrades Hit Controls and Pharma

Two notable downgrades landed this week. Johnson Controls International and Bristol-Myers Squibb both took cuts from Wall Street analysts.

Johnson Controls slipped a notch in consensus ratings. The building automation giant carries an $88.8 billion market cap. Its average analyst target price moved marginally to $162.05. Short interest sits low at 1.6% of free float, so bears aren't piling in yet.

Bristol-Myers also absorbed a downgrade. The pharma major's consensus shifted from Hold toward Sell territory. The average target fell to $64.91, down from $64.21. At $133 billion market cap, any rating slip draws attention.

On the positive side, Royal Caribbean Cruises attracted a fresh new recommendation from the analyst community. Consensus holds at 16 Buys, 8 Holds, and just 1 Sell. The average target sits at $349.73. Short interest at 5.1% of FF suggests some skeptics remain.

Amazon saw its average target price nudge higher to $321.95. The consensus remains heavily weighted to Buy, with 59 Buy ratings versus just 3 Holds.

Paychex also received a consensus target upgrade, rising to $109.57. The payroll processor maintains a balanced analyst view with 12 Holds and 4 Sells.